🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07566286
Recruiting Not applicable

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

NCT07566286 · tracked via the Priya Life Science USA tracker
Sponsor
Galderma R&D
Phase
Not applicable
Started
2026-06-03
Last updated
2026-08-14

Condition(s) studied

Chin Augmentation

Investigational drug(s) / intervention(s)

Restylane Lyft with Lidocaine

Restylane Lyft with Lidocaine: Sterile gel of hyaluronic acid.

Study summary

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Eligibility

Sex
ALL
Min age
22 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: 1. Males or non-pregnant, non-breastfeeding females, 22 years of age or older. 2. Intent to receive treatment for augmentation and correction of retrusion in the chin region. Exclusion Criteria: 1. Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins. 2. Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics. 3. Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of these conditions. 4. Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from subnasale. 5. Any previous aesthetic procedures or implants. 6. Presence of any disease or lesions near or on the area to be treated.

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
Galderma Investigational Site # 8680 Westport Connecticut Recruiting
Galderma Investigational Site # 8774 Boynton Beach Florida Recruiting
Galderma Investigational Site # 7030 Coral Gables Florida Recruiting
Galderma Investigational Site # 8682 Coral Gables Florida Recruiting
Galderma Investigational Site # 7042 Atlanta Georgia Recruiting
Galderma Investigational Site # 7043 Bethesda Maryland Not Yet Recruiting
Galderma Investigational Site # 7118 Nashville Tennessee Recruiting
Galderma Investigational Site # 8662 Spring Texas Recruiting

More Galderma R&D trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07566286 on ClinicalTrials.gov ↗ ← All trials in the USA